Group CEO and Managing Director

TELIX INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Stockholders

Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded

Telix Pharmaceuticals reports Q3 revenue $206M vs. $135M last year

Telix Pharmaceuticals raises FY25 revenue view to $800M-$820M from $770M-$800M

Global Clinical Lead (Clinical Scientist)

Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company focused on precision medicine for cancer and rare diseases. The Global Clinical Lead will oversee the clinical development of novel imaging agents, ensuring alignment with commercial objectives and regulatory requirements while collaborating with various teams to drive clinical strategy and execution.

Sign up with Google

Sign in with Google